Provided by Tiger Trade Technology Pte. Ltd.

VYNE Therapeutics Inc.

0.5858
+0.01061.84%
Volume:37.70K
Turnover:22.07K
Market Cap:19.50M
PE:-0.74
High:0.5897
Open:0.5688
Low:0.5688
Close:0.5752
52wk High:2.83
52wk Low:0.2805
Shares:33.29M
Float Shares:30.82M
Volume Ratio:0.20
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7884
EPS(LYR):-0.9353
ROE:-70.67%
ROA:-41.51%
PB:0.61
PE(LYR):-0.63

Loading ...

VYNE Therapeutics Amends Merger Terms with Yarrow Bioscience

TIPRANKS
·
Jan 31

Vyne Therapeutics Amends Merger Agreement With Yarrow Bioscience

Reuters
·
Jan 31

Vyne Therapeutics and Yarrow Bioscience announce merger in all-stock deal

Reuters
·
Dec 17, 2025

Vyne Therapeutics - to Declare Cash Dividend to Pre-Merger Vyne Stockholders of $14.5 Mln-$16.5 Mln

THOMSON REUTERS
·
Dec 17, 2025

Vyne Therapeutics Inc - Combined Company to Trade Under Ticker 'Yarw'

THOMSON REUTERS
·
Dec 17, 2025

Vyne Therapeutics Inc - Pre-Closing Financings of $200 Mln to Fund Operations Into 2028

THOMSON REUTERS
·
Dec 17, 2025

Vyne Therapeutics Inc - Combined Company to Be Named Yarrow Bioscience, Led by Rebecca Frey

THOMSON REUTERS
·
Dec 17, 2025

VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement

GlobeNewswire
·
Dec 17, 2025

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM

Reuters
·
Dec 17, 2025

Vyne Therapeutics Inc. Held Annual Stockholder Meeting

Reuters
·
Dec 13, 2025

VYNE Therapeutics Q3 Revenue USD 169 Thousand

Reuters
·
Nov 20, 2025

Vyne Therapeutics Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Nov 13, 2025

VYNE Therapeutics (VYNE) Gets a Buy from TD Cowen

TIPRANKS
·
Nov 08, 2025

VYNE Therapeutics Q3 EPS $(0.17) Misses $(0.13) Estimate, Sales $169.000K Beat $100.000K Estimate

Benzinga
·
Nov 06, 2025

VYNE Therapeutics reports Q3 EPS (17c) vs (29c) last year

TIPRANKS
·
Nov 06, 2025

VYNE Therapeutics Q3 net loss narrows, strategic review ongoing

Reuters
·
Nov 06, 2025

Vyne Therapeutics reports third quarter results and updates on pipeline progress

Reuters
·
Nov 06, 2025

BRIEF-VYNE Therapeutics Q3 Revenue USD 169 Thousand

Reuters
·
Nov 06, 2025

Vyne Therapeutics Q3 EPS From Cont Ops USD -0.17

THOMSON REUTERS
·
Nov 06, 2025

Vyne Therapeutics Q3 Revenue USD 169 Thousand

THOMSON REUTERS
·
Nov 06, 2025